• Thought Leader Series: Our responsibility to patients who can’t afford to wait, Professor John Zalcberg

  • Oct 11 2022
  • Duración: 32 m
  • Podcast

Thought Leader Series: Our responsibility to patients who can’t afford to wait, Professor John Zalcberg  Por  arte de portada

Thought Leader Series: Our responsibility to patients who can’t afford to wait, Professor John Zalcberg

  • Resumen

  • Professor John Zalcberg
    Head, Cancer Research Program, School of Public Health, Monash University
     
    Our responsibility to patients who can’t afford to wait

    In this episode, RCA Chief Executive Richard Vines speaks to Professor John Zalcberg about:
    - How he was destinated to be in medicine since childhood
    - Why he chose to specialise in cancer care
    - The challenges around making clinical trials more ‘ambitious’
    - How wealth impacts your access to cancer drugs in Australia
    - How the cost of drugs to the community trumps urgent provision to patients
    - The challenges of working within the current health system
    - Ideas to help speed up critical access to treatment
    - The untapped potential of patient data

    More about Professor John Zalcberg
    John was Director of Cancer Medicine at the Peter MacCallum Cancer Centre for 17 years, as well as their Chief Medical Officer for six. He is highly regarded both nationally and internationally as a leader in his field, is a mentor to some of the most accomplished clinicians in Australia, and is a well-known advocate for patient access to new cancer drugs.  

    #thoughtleaderseries

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Thought Leader Series: Our responsibility to patients who can’t afford to wait, Professor John Zalcberg

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.